| For: | Sun X, Suo J, Yan J. Immunotherapy in human colorectal cancer: Challenges and prospective. World J Gastroenterol 2016; 22(28): 6362-6372 [PMID: 27605872 DOI: 10.3748/wjg.v22.i28.6362] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i28/6362.htm |
| Number | Citing Articles |
| 1 |
Baojun Duan, Yaning Zhao, Jun Bai, Jianhua Wang, Xianglong Duan, Xiaohui Luo, Rong Zhang, Yansong Pu, Mingqing Kou, Jianyuan Lei, Shangzhen Yang. Gastrointestinal Cancers. 2022; doi: 10.36255/exon-publications-gastrointestinal-cancers-colorectal-cancer
|
| 2 |
Xianjun Rao, Guodong Huang, Jiaxuan Li, Chunyu Wu, Min Yang, Xianfeng Rao, Zixing Qian, Liji Chen, Yang Yang, Wei Wei. Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1775386
|
| 3 |
Saloni Kakkar, Sumit Tahlan, Siong Meng Lim, Kalavathy Ramasamy, Vasudevan Mani, Syed Adnan Ali Shah, Balasubramanian Narasimhan. Benzoxazole derivatives: design, synthesis and biological evaluation. Chemistry Central Journal 2018; 12(1) doi: 10.1186/s13065-018-0459-5
|
| 4 |
Huihong Jiang, Erjiang Tang, Dan Xu, Ying Chen, Yong Zhang, Min Tang, Yihua Xiao, Zhiyong Zhang, Xiaxing Deng, Huaguang Li, Moubin Lin. Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer. Oncotarget 2017; 8(18) doi: 10.18632/oncotarget.16167
|
| 5 |
Salomon M. Manz, Marco Losa, Ralph Fritsch, Michael Scharl. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211002018
|
| 6 |
Zuxiong Tang, Yufan Wu, Ding Sun, Xiaofeng Xue, Lei Qin. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients. Bioscience Reports 2021; 41(10) doi: 10.1042/BSR20210039
|
| 7 |
Shan Xie, Jia Huang, Qin Qiao, Wenjuan Zang, Shanjuan Hong, Haidong Tan, Chen Dong, Zhiying Yang, Ling Ni. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors. Cancer Immunology, Immunotherapy 2018; 67(11) doi: 10.1007/s00262-018-2227-8
|
| 8 |
Feng Chen, Lijuan Pei, Siyao Liu, Yan Lin, Xinyin Han, Erhong Meng, Xintong Wang, Shuai Hong, Dongliang Wang, Feide Liu, Yang Fei, Guangda Wang. Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.684349
|
| 9 |
Mengmeng Lv, Sheng Guo, Xinyu Zhang, Yan Zou, Qiang Chen, Chongyi Zang, Shuo Huang, Yuhan Hu, Yanling Wang, Qianqing Wang, Jiateng Zhong. Attenuated Salmonella-delivered PD-1 siRNA enhances the antitumor effects of EZH2 inhibitors in colorectal cancer. International Immunopharmacology 2023; 124 doi: 10.1016/j.intimp.2023.110918
|
| 10 |
Virgilio S. Silva, Rachel P. Riechelmann, Celso A. Mello, Tiago Felismino, Rodrigo Taboada. The Current and Evolving Role of Immunotherapy in Metastatic Colorectal
Cancer. Current Cancer Drug Targets 2022; 22(8) doi: 10.2174/1568009622666220224110912
|
| 11 |
Yulia P. Tupolova, Leonid D. Popov, Valery G. Vlasenko, Konstantin B. Gishko, Anna A. Kapustina, Alexandra G. Berejnaya, Yuliya A. Golubeva, Lyubov S. Klyushova, Elizaveta V. Lider, Vladimir A. Lazarenko, Stanislav S. Bachurin, Igor N. Shcherbakov. Crystal structure and cytotoxic activity of Cu(ii) complexes with bis-benzoxazolylhydrazone of 2,6-diacetylpyridine. New Journal of Chemistry 2023; 47(31) doi: 10.1039/D3NJ02445H
|
| 12 |
Yushan Zhang, Ni Meng, Xiaolong Cheng, Mengyao Sun, Qicheng Feng, Xueke Sun, Jing Chen, Xifu Liu. A novel B7-H4/CD3/CD28 trispecific antibody with the SpyTag-SpyCatcher technology suppresses the growth of colorectal cancer. International Immunopharmacology 2025; 167 doi: 10.1016/j.intimp.2025.115719
|
| 13 |
Debora Basile, Silvio Ken Garattini, Marta Bonotto, Elena Ongaro, Mariaelena Casagrande, Monica Cattaneo, Valentina Fanotto, Elisa De Carlo, Fotios Loupakis, Federica Urbano, Francesca V. Negri, Nicoletta Pella, Marco Russano, Oronzo Brunetti, Mario Scartozzi, Daniele Santini, Nicola Silvestris, Andrea Casadei Gardini, Marco Puzzoni, Lorenzo Calvetti, Nadia Cardarelli, Giuseppe Aprile. Immunotherapy for colorectal cancer: where are we heading?. Expert Opinion on Biological Therapy 2017; 17(6) doi: 10.1080/14712598.2017.1315405
|
| 14 |
Aaron J Franke, William Paul Skelton, Jason S Starr, Hiral Parekh, James J Lee, Michael J Overman, Carmen Allegra, Thomas J George. Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches. JNCI: Journal of the National Cancer Institute 2019; 111(11) doi: 10.1093/jnci/djz093
|
| 15 |
Yanhui Yu, Xiuyun Lu, Chuandong Yang, Fengxiang Yin. <p>Long Noncoding RNA LINC00173 Contributes to the Growth, Invasiveness and Chemo-Resistance of Colorectal Cancer Through Regulating miR-765/PLP2 Axis</p>. Cancer Management and Research 2020; doi: 10.2147/CMAR.S251029
|
| 16 |
Li Chen, Xiaoying Jiang, Yuanheng Li, Qiqi Zhang, Qing Li, Xiaoyan Zhang, Meng Zhang, Qiongfang Yu, Dian Gao. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Clinical Immunology 2022; 237 doi: 10.1016/j.clim.2022.108962
|
| 17 |
Ching‐Hsin Huang, Natalie Mendez, Oscar Hernandez Echeagaray, Joi Weeks, James Wang, Shiyin Yao, Sarah L. Blair, Natalie Gude, William C. Trogler, Dennis A. Carson, Tomoko Hayashi, Andrew C. Kummel. Immunostimulatory TLR7 Agonist‐Nanoparticles Together with Checkpoint Blockade for Effective Cancer Immunotherapy. Advanced Therapeutics 2020; 3(6) doi: 10.1002/adtp.201900200
|
| 18 |
Shelby N. Bess, Gage J. Greening, Timothy J. Muldoon. Efficacy and clinical monitoring strategies for immune checkpoint inhibitors and targeted cytokine immunotherapy for locally advanced and metastatic colorectal cancer. Cytokine & Growth Factor Reviews 2019; 49 doi: 10.1016/j.cytogfr.2019.10.002
|
| 19 |
Stuart P. Berzins, Morgan E. Wallace, George Kannourakis, Jason Kelly. A Role for MAIT Cells in Colorectal Cancer. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00949
|
| 20 |
Danyang Wang, Hangyu Zhang, Tao Xiang, Gang Wang. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.762341
|
| 21 |
Dajia Lin, Shishun Zhong, Jinsheng Liu. Targeting mitochondrial dysfunction in MAIT cells: Potential immunotherapeutic treatment for colorectal cancer. Medical Hypotheses 2021; 146 doi: 10.1016/j.mehy.2020.110358
|
| 22 |
Ranmali Ranasinghe, Michael Mathai, Anthony Zulli. A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(2) doi: 10.1016/j.bbcan.2022.188699
|
| 23 |
Kumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, Rupesh Shrestha, Lei Zhang, Maen Abdelrahim, Robert S. Chapkin, Stephen Safe. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion. Cancer Immunology, Immunotherapy 2023; 72(12) doi: 10.1007/s00262-023-03530-3
|
| 24 |
Peng Wang, Chun Li, Xuzhe Ma, Xiaodong Gai. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients. Medicine 2020; 99(18) doi: 10.1097/MD.0000000000020044
|
| 25 |
Yihenew Simegniew Birhan, Hsieh-Chih Tsai. Recent developments in selenium-containing polymeric micelles: prospective stimuli, drug-release behaviors, and intrinsic anticancer activity. Journal of Materials Chemistry B 2021; 9(34) doi: 10.1039/D1TB01253C
|
| 26 |
Marica Garziera, Saverio Virdone, Elena De Mattia, Lucia Scarabel, Erika Cecchin, Jerry Polesel, Mario D’Andrea, Nicoletta Pella, Angela Buonadonna, Adolfo Favaretto, Giuseppe Toffoli. HLA-G 3′UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(7) doi: 10.3390/ijms18071366
|
| 27 |
Xianzhe Yu, Lingling Zhu, Jiewei Liu, Ming Xie, Jiang Chen, Jianguo Li. <p>Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S271955
|
| 28 |
Alessandro Ottaiano, Valerio Scotti, Chiara De Divitiis, Monica Capozzi, Carmen Romano, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Anna Nappi, Valeria Vicario, Alfonso De Stefano, Salvatore Tafuto, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone. Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors. Oncotarget 2018; 9(81) doi: 10.18632/oncotarget.25834
|
| 29 |
Carolina Mendonça Gorgulho, Anuradha Krishnamurthy, Anastasia Lanzi, Jérôme Galon, Franck Housseau, Ramon Kaneno, Michael T. Lotze. Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer. Journal of Immunotherapy 2021; 44(2) doi: 10.1097/CJI.0000000000000357
|
| 30 |
Ying Feng, Zhaoting Yang, Chengye Zhang, Nan Che, Xingzhe Liu, Yanhua Xuan. B7-H4 induces epithelial–mesenchymal transition and promotes colorectal cancer stemness. Pathology - Research and Practice 2021; 218 doi: 10.1016/j.prp.2020.153323
|
| 31 |
Xinyu Chai, Yiwen Zhang, Zhihui Shi, Ruiling Yang, Xumin Liu, Yueting Zhou, Caiyang Li, Zhenhui Li. An Overview of Predictive Biomarkers and Detection Approaches for Immunotherapy Response in GI Malignancies. Journal of Gastroenterology and Hepatology 2025; 40(5) doi: 10.1111/jgh.16930
|
| 32 |
Ke Wang, Hui Gong, Rui Chai, Hang Yuan, Yanxia Chen, Jinlin Liu. RETRACTED: Aberrant frequency of IL-35 producing B cells in colorectal cancer patients. Cytokine 2018; 102 doi: 10.1016/j.cyto.2017.10.011
|
| 33 |
Jane Thomas, Alexis Leal, Michael J. Overman. Clinical Development of Immunotherapy for Deficient Mismatch Repair Colorectal Cancer. Clinical Colorectal Cancer 2020; 19(2) doi: 10.1016/j.clcc.2020.02.002
|
| 34 |
Xing He, Huanrong Lan, Ketao Jin, Fanlong Liu. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1237764
|
| 35 |
Claudia Maletzki, Philine Scheinpflug, Anika Witt, Ernst Klar, Michael Linnebacher. Targeting Immune-Related Molecules in Cancer Therapy: A ComprehensiveIn VitroAnalysis on Patient-Derived Tumor Models. BioMed Research International 2019; 2019 doi: 10.1155/2019/4938285
|
| 36 |
Itzel Medina-Andrade, Jonadab E. Olguín, Tonathiu Rodríguez, Luis I. Terrazas. Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives. 2021; doi: 10.1016/B978-0-12-822028-3.00003-0
|
| 37 |
Jun-Peng Pei, Chun-Dong Zhang, Yu Liang, Cheng Zhang, Kun-Zhe Wu, Zhe-Ming Zhao, Dong-Qiu Dai. Novel Nomograms Individually Predicting Overall Survival of Non-metastatic Colon Cancer Patients. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00733
|
| 38 |
Zienab Etwebi, Jason R Goldsmith, Mayassa Bou-Dargham, Yuhua Tian, Ryan Hood, Nina Spitofsky, Mingyue Li, Honghong Sun, Yunwei Lou, Suxia Liu, Christopher Lengner, Youhai H Chen. TIPE2 Promotes Tumor Initiation But Inhibits Tumor Progression in Murine Colitis-Associated Colon Cancer. Inflammatory Bowel Diseases 2022; 28(5) doi: 10.1093/ibd/izab306
|
| 39 |
Ramón Cantero-Cid, José Casas-Martin, Enrique Hernández-Jiménez, Carolina Cubillos-Zapata, Aníbal Varela-Serrano, José Avendaño-Ortiz, Marta Casarrubios, Karla Montalbán-Hernández, Ignacio Villacañas-Gil, Laura Guerra-Pastrián, Begoña Peinado, Cristóbal Marcano, Luis A Aguirre, Eduardo López-Collazo. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4853-0
|
| 40 |
Yifei Gao, Ximo Wang. Current status and progress of diagnosis and treatment of postoperative recurrence of gastrointestinal peritoneal metastases. Holistic Integrative Oncology 2025; 4(1) doi: 10.1007/s44178-025-00163-7
|